2026 NPPES data Pain Medicine Physician NPI 1538302179
Verify on CMS →

GULLE AWAN

Pain Medicine Physician in SMITHTOWN, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 138 beneficiaries · Pain Medicine Physician avg: 2K
Generic prescribing
93%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
85.8968/100
▲ 3 pts above national avg 83.1 · [object Object]
Industry payments
$237.81
10 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

GULLE AWAN reported a CMS MIPS final score of 85.8968/100 — above the 83.1 national average — and filed 1,376 Medicare Part D claims in 2023.

85.8968/100
MIPS score · +3 vs avg
1K
Part D claims, 2023
93%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

GULLE AWAN's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

86 49th percentile higher than 49% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

GULLE AWAN practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about GULLE AWAN?

High performer (top quartile)

NPI registry status

Active

Issued 04/13/2009

NPI 1538302179

Primary specialty

Pain Medicine Physician

Niche

951 US NPIs in this specialty

Medicare Part D claims

1,376 34% vs specialty avg

2023 prescription claims

Specialty avg: 2,078

MIPS final score

85.8968/100 2.7968000000000046% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in New York

How Pain Medicine Physician compares to other specialties among New York providers

New York providers

Pain Medicine Physician share within New York

1. Pain Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pain Medicine Physician share within New York

Medicare quality performance — MIPS

GULLE AWAN's 2023 MIPS final score plotted against the Pain Medicine Physician national average

High performer (top quartile)
MIPS Final Score
85.8968/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Pain Medicine Physician) — 85.8968/100 vs national avg 83.1

0%100%National avg83%85.9%
MIPS final score (Pain Medicine Physician) — 85.8968/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

GULLE AWAN appears in the CMS NPPES registry as a Pain Medicine Physician provider at 994 W JERICHO TPKE, SMITHTOWN, NY, 11787, with a listed phone of (631) 543-1440. NPI 1538302179 was issued on 04/13/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what AWAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,376 prescription claims written by this provider, covering 138 Medicare beneficiaries and totaling roughly $77K in drug spend, split 7% brand-name and 93% generic by claim count, with an opioid prescribing rate of 58.9%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 85.8968/100 for the 2023 performance year (Quality 100, Cost 52.9892), compared with the national average of 83.1.

Pain Medicine Physician is a narrow specialty nationwide, with 951 enrolled providers across 49 states and an average of 2,078 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

994 W JERICHO TPKE
SMITHTOWN, NY 11787

Provider Details

NPI 1538302179
Specialty Pain Medicine Physician
Gender Female
NPI Issued 04/13/2009

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

85.8968
Final Score
Avg: 83.1
100
Quality
52.9892
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where GULLE AWAN bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

TIMOTHY D. GROTH MD PC
SMITHTOWN, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for GULLE AWAN. Source: openpaymentsdata.cms.gov.

Total received

$238

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to GULLE AWAN. To verify GULLE AWAN's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

GULLE AWAN — brand share 7.0%
Specialty average (est.)

7% brand-name claims vs 93% generic, on 1,376 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,376
Total Claims
$77K
Total Drug Cost
138
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,439
Total Day Supply
41,317
Brand vs Generic
7% brand / 93% generic
Brand Drug Cost
$42K
Generic Drug Cost
$35K
Opioid Claims
811 (58.9% rate)

Patient Demographics

Average Patient Age
69.4 years
Avg HCC Risk Score
1.28
Gender Split
72% female / 28% male
Age Distribution
<65: 35, 65-74: 64, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What GULLE AWAN prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
443
Gabapentin
110
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
105
Cyclobenzaprine Hcl
97
Tizanidine Hcl
72
Lidocaine
65
Tramadol Hcl
61
Celecoxib
54
Meloxicam
54
Morphine Sulfate Er
Morphine Sulfate
39

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pain Medicine Physician Overview

How GULLE AWAN fits within the Pain Medicine Physician landscape nationally.

951
Pain Medicine Physician Providers in US
49
States with Pain Medicine Physician
2,078
Avg Claims per Provider

GULLE AWAN's 1,376 claims are below the specialty average of 2,078.

Nearby Pain Medicine Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as AWAN.

Compare Pain Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is GULLE AWAN's specialty?
GULLE AWAN specializes in Pain Medicine Physician and practices in SMITHTOWN, New York.
How much does GULLE AWAN prescribe under Medicare Part D?
In 2023, GULLE AWAN wrote 1,376 Medicare Part D claims totaling $77K in drug costs for 138 beneficiaries.
What is GULLE AWAN's Medicare quality score?
GULLE AWAN has a CMS MIPS Final Score of 85.8968/100 (Quality: 100, Cost: 52.9892). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is GULLE AWAN located?
GULLE AWAN is located at 994 W JERICHO TPKE, SMITHTOWN, NY, 11787. Phone: (631) 543-1440.
What is GULLE AWAN's NPI number?
GULLE AWAN's National Provider Identifier (NPI) is 1538302179, issued on 04/13/2009.
Does GULLE AWAN prescribe more brand-name or generic drugs?
GULLE AWAN's prescribing is 7% brand-name and 93% generic drugs by claim count, with $42K in brand drug costs.
Does GULLE AWAN prescribe opioids?
Yes, GULLE AWAN had 811 opioid claims in 2023 with an opioid prescribing rate of 58.9%.
How many Pain Medicine Physician providers are there in the US?
There are 951 Pain Medicine Physician providers across 49 states in the US. The average Pain Medicine Physician provider writes 2,078 Medicare Part D claims per year.
What drugs does GULLE AWAN prescribe most often?
Based on 2023 Medicare Part D data, GULLE AWAN's most frequently prescribed drugs include Oxycodone-Acetaminophen, Gabapentin, Hydrocodone-Acetaminophen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does GULLE AWAN accept Medicare?
GULLE AWAN appears in CMS Medicare data with 1,376 Part D claims and 138 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify GULLE AWAN's credentials?
GULLE AWAN's NPI is 1538302179. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology